These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype? Lønborg JT Heart; 2015 Oct; 101(20):1612-8. PubMed ID: 26130664 [TBL] [Abstract][Full Text] [Related]
23. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?]. Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337 [TBL] [Abstract][Full Text] [Related]
24. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial. Garcia-Dorado D; García-del-Blanco B; Otaegui I; Rodríguez-Palomares J; Pineda V; Gimeno F; Ruiz-Salmerón R; Elizaga J; Evangelista A; Fernandez-Avilés F; San-Román A; Ferreira-González I Int J Cardiol; 2014 Dec; 177(3):935-41. PubMed ID: 25449504 [TBL] [Abstract][Full Text] [Related]
25. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Atar D; Huber K; Rupprecht HJ; Kopecky SL; Schwitter J; Theek C; Brandl K; Henning R; Geudelin B Cardiology; 2007; 108(2):117-23. PubMed ID: 17019083 [TBL] [Abstract][Full Text] [Related]
26. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Grygier M; Araszkiewicz A; Lesiak M; Janus M; Kowal J; Skorupski W; Pyda M; Mitkowski P; Grajek S Am J Cardiol; 2011 Apr; 107(8):1131-5. PubMed ID: 21310372 [TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999 [TBL] [Abstract][Full Text] [Related]
28. Improving myocardial injury, infarct size, and myocardial salvage in the era of primary PCI for STEMI. Ndrepepa G Coron Artery Dis; 2015 Jun; 26(4):341-55. PubMed ID: 25715338 [TBL] [Abstract][Full Text] [Related]
29. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction]. Yang YJ; Zhao JL Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176 [No Abstract] [Full Text] [Related]
30. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications]. Paneni F; Costantino S; Cosentino F G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758 [TBL] [Abstract][Full Text] [Related]
31. Myocardial protection at a crossroads: the need for translation into clinical therapy. Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA; Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864 [TBL] [Abstract][Full Text] [Related]
32. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. Gerczuk PZ; Kloner RA J Am Coll Cardiol; 2012 Mar; 59(11):969-78. PubMed ID: 22402067 [TBL] [Abstract][Full Text] [Related]
33. Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Kloner RA Circ Res; 2013 Aug; 113(4):451-63. PubMed ID: 23908332 [TBL] [Abstract][Full Text] [Related]
34. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944 [TBL] [Abstract][Full Text] [Related]
35. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction. Faruk Akturk I; Arif Yalcin A; Biyik I; Sarikamis C; Turhan Caglar N; Erturk M; Celik O; Uzun F; Murat Caglar I; Oner E Minerva Cardioangiol; 2014 Oct; 62(5):389-97. PubMed ID: 24699550 [TBL] [Abstract][Full Text] [Related]
36. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. Jaffe R; Dick A; Strauss BH JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430 [TBL] [Abstract][Full Text] [Related]
37. Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to be Learnt by Translating Results from Animal Models to the Clinical Settings. Birnbaum GD; Birnbaum I; Ye Y; Birnbaum Y Cardiovasc Drugs Ther; 2015; 29(5):461-7. PubMed ID: 26303765 [TBL] [Abstract][Full Text] [Related]